XERS vs JBIO
Comparison between Xeris Biopharma Holdings Inc (XERS, Company) and Jade Biosciences Inc (JBIO, Company).
Both XERS and JBIO are from the Healthcare sector.
5-Year PerformanceXERS has outperformed JBIO, delivering a return of +29.1% compared to -41.7%
XERS vs JBIO - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
XERS vs JBIO - Historical Returns
Returns include dividend reinvestment.
XERS vs JBIO - Annual Returns (2018 - 2026)
Returns include dividend reinvestment.
| Year | XERS | JBIO |
|---|---|---|
| 2026 | +13.33% | +68.15% |
| 2025 | +126.88% | -79.69% |
| 2024 | +49.67% | -87.85% |
| 2023 | +109.82% | -16.28% |
| 2022 | -52.67% | +168.07% |
| 2021 | -44.82% | -48.36% |
| 2020 | -26.57% | N/A |
| 2019 | -59.71% | N/A |
| 2018 | -15.92% | N/A |
XERS vs JBIO Drawdown Comparison
The maximum drawdown for XERS was -96.22%, occurring on Jan 5, 2023. This drawdown has not yet recovered.
The maximum drawdown for JBIO was -99.22%, occurring on Jun 13, 2025. This drawdown has not yet recovered.
The current XERS drawdown is -69.41%. The current JBIO drawdown is -97.26%.
| Rank | XERS | JBIO |
|---|---|---|
| #1 | -96.22% Sep 10, 2018 - Jan 5, 2023 | -99.22% Apr 1, 2024 - Jun 13, 2025 |
| #2 | -17.12% Jul 24, 2018 - Aug 14, 2018 | -68.61% Dec 12, 2022 - Apr 1, 2024 |
| #3 | -10.98% Jun 21, 2018 - Jul 20, 2018 | -63.86% Jun 30, 2021 - Aug 1, 2022 |
| #4 | -7.87% Aug 14, 2018 - Aug 22, 2018 | -42.73% Aug 12, 2022 - Dec 12, 2022 |
| #5 | -3.41% Aug 23, 2018 - Sep 7, 2018 | -4.56% Aug 5, 2022 - Aug 12, 2022 |
| #6 | -3.07% Jul 20, 2018 - Jul 24, 2018 | N/A |
Correlation
Correlation between XERS and JBIO is -0.73 which considered as a strong negative correlation - the stocks tend to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks